Invesco Ltd: Form 8.3 - BHP Group Ltd
May 24, 2024 08:49 ET | Invesco Ltd.
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION   (a)Full name of...
ExelaTech_logo.png
Exela Technologies, Inc. to Host First Quarter 2024 Financial Results Conference Call
May 24, 2024 08:45 ET | Exela Technologies, Inc.
IRVING, Texas, May 24, 2024 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ:XELA, XELAP), a global business process automation (“BPA”) leader, will host a conference...
CG Logo.jpg
Form 8.3 - [KEYWORDS STUDIOS PLC - 23 05 2024] - (CGWL)
May 24, 2024 08:45 ET | Canaccord Genuity Wealth Limited
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...
finacialnews-logo-final-01 (2).png
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
May 24, 2024 08:45 ET | FN Media Group LLC
PALM BEACH, Fla., May 24, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the...
Invesco Ltd: Form 8.3 - Anglo American PLC
May 24, 2024 08:42 ET | Invesco Ltd.
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION   (a)Full name of...
Final Esplit logo.jpg
E Split Corp. Class A Distribution
May 24, 2024 08:37 ET | E Split Corp.
TORONTO, May 24, 2024 (GLOBE NEWSWIRE) -- E Split Corp. (TSX: ENS) (the “Fund”) is pleased to announce that a distribution for May 2024 will be payable to Class A shareholders of E Split Corp. as...
Stereotaxis Logo - New Tagline - Black Text.png
Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework
May 24, 2024 08:37 ET | Stereotaxis, Inc.
Stereotaxis has received CE Mark recertification under the EU’s new Medical Device Regulation (MDR) regulatory framework for all available devices.
Lilium sq.png
Lilium Announces Pricing of $114 Million Financing
May 24, 2024 08:36 ET | Lilium GmbH
MUNICH, Germany, May 24, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (NASDAQ: LILM) (“Lilium” or the “Company”), developer of the first all-electric vertical take-off and landing (“eVTOL”) jet and global...
download.jpg
QuidelOrtho (QDEL) Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman
May 24, 2024 08:36 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 24, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges QuidelOrtho Corporation (NASDAQ: QDEL) investors who suffered substantial losses to submit your losses now. Class Period:...
Social-Media_VIC_Announcment_2.png
Clean Energy and Precious Metals Hybrid Virtual Investor Conference: Presentations Now Available for Online Viewing
May 24, 2024 08:35 ET | Virtual Investor Conferences
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Clean Energy and Precious...